Evidence map›Paper›PMID 41287060›Full record

ArticleHarm reduction journal2025

Co-producing a peer-led health conversation tool for the health services workforce to facilitate safer use of anabolic-androgenic steroids.

Timothy Piatkowski, Sonya Weith, Emma Kill, Brooke Walters, Geoff Davey, Cameron Francis, Steph Reeve, Ross Coomber, Jason Ferris, Monica Barratt and 2 more

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Timothy PiatkowskiSchool of Applied Psychology and Centre for Mental Health, Griffith University, Brisbane, QLD, Australia. t.piatkowski@uq.edu.au.
Sonya WeithQueensland Injectors Voice for Advocacy and Action, Brisbane, QLD, Australia.
Emma KillSchool of Applied Psychology and Centre for Mental Health, Griffith University, Brisbane, QLD, Australia.
Brooke WaltersQueensland Injectors Voice for Advocacy and Action, Brisbane, QLD, Australia.
Geoff DaveyQueensland Injectors Health Network, Brisbane, Australia.
Cameron FrancisThe Loop Australia, Brisbane, Australia.
Steph ReeveSchool of Applied Psychology and Centre for Mental Health, Griffith University, Brisbane, QLD, Australia.
Ross CoomberDepartment of Sociology, Social Policy and Criminology, Faculty of Humanities and Social Sciences, University of Liverpool, Liverpool, UK.
Jason FerrisCentre for Health Services Research, University of Queensland, Brisbane, QLD, Australia.
Monica BarrattThe Loop Australia, Brisbane, Australia.
Cheneal PuljevicThe Loop Australia, Brisbane, Australia.
Emily StockingsThe Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIllicit anabolic-androgenic steroid (AAS) use poses physical and psychosocial risks. These issues are exacerbated by inadequate public health responses and well-meaning yet inadequately trained health workers. This study presents the development of a collaboratively designed health conversation tool, which equips health workers' with a number of questions and strategic information to promote well-informed use for people who use AAS.

methodsThis qualitative, multi-stage study co-produced a health conversation, a guided conversation tool that aims to incorporate a brief assessment, knowledge provision, sharing of harm reduction strategies and advice for health workers engaging with people who use AAS in community settings. The iterative co-design process followed a five-stage pedagogical approach (ideation, planning, creation, programming and sharing), guided by semi-structured interviews with 25 people who use AAS and a workshop focus group of 6 experienced AAS peers for further refinement. Guided discussion included exploration or harms, health enhancement and required resources. Qualitative responses were synthesised via inductive analysis to identify key themes, from which the conversation was developed and then tested with the AAS peer group.

resultsThere were two core findings from this research. Firstly, insights gained from people who use AAS in the key current practices related to safer use of these drugs. Secondly, based on these insights, a health conversation tool was co-produced, which encompasses a brief assessment, gauging people's experiences with AAS, confidence in their knowledge, and support systems. The tool provides health workers with a suite of harm reduction strategies to offer to people who use AAS, such as proper injection techniques, considerations regarding their usage strategy, and suggestions for health monitoring.

conclusionsThe collaborative design process ensured the health conversation tool reflected the lived-living experiences and priorities of people who use AAS, specifically fostering trust and engagement. This peer-driven approach filled gaps in harm reduction services, promoting informed decisions regarding AAS use as well as some health strategies. Expanding the peer workforce and integrating digital platforms can enhance the reach and sustainability of tailored harm reduction interventions for AAS and other communities.

Indexed as

Anabolic AgentsAndrogensHarm ReductionHealth CommunicationHealth PersonnelPeer GroupSubstance-Related DisordersAdultFemaleFocus GroupsHumansMaleMiddle AgedQualitative ResearchAnabolic AgentsAndrogensAnabolic–androgenic steroidsHarm reductionHealth servicesImage and performance enhancing drugsLived-living experiencePeers

Identifiers

PMID41287060
PMCPMC12750734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.